

RadNet (RDNT) reports record Q4 revenue and adjusted EBITDA, beating estimates and announcing acquisition of Paris-based AI firm Gleamer.
You can purchase shares of RadNet (NASDAQ:RDNT) through any online brokerage.
Other companies in RadNet’s space includes: CVS Health Corp (NYSE:CVS), The Cigna Group (NYSE:CI), Labcorp Holdings Inc (NYSE:LH), Quest Diagnostics Inc (NYSE:DGX) and Guardant Health Inc (NASDAQ:GH).
RadNet has a consensus price target of $84.50.
The stock price for RadNet (NASDAQ: RDNT) is $76 last updated November 6, 2026 at 4:00 PM EST.
There are no upcoming dividends for RadNet.
RadNet does not have any upcoming earnings scheduled.
There is no upcoming split for RadNet.
RadNet is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the...